TGA investigates duloxetine contamination

Sponsors report N-nitroso-duloxetine levels in some duloxetine medications are currently above “acceptable intake” limits  Patients are being urged not to stop taking duloxetine medications while the Therapeutic Goods Administration (TGA) investigates reports of contamination.   In a safety advisory issued by the TGA on Monday (27 November), the regulator noted that a number of sponsors